Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 18 matching records
MANUFACTURING OF PLASMID AND VECTOR AND GLP DOSE-ESCALATION TOXICOLOGY STUDIES IN NORMAL RATS AND NORMAL NHPSDepartment of Health and Human Services$10.6M obligationsEnds Sep 29, 2030
1800013I BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 BASE…Department of Health and Human Services$9.3M obligationsEnds Dec 14, 2027
DEVELOPMENT OF ASSAYS AND REAGENTS FOR MONKEYPOX VACCINESDepartment of Health and Human Services$3.8M obligationsEnds Dec 31, 2026
KALER TO - VIRAL GENE THERAPY FOR MENKES DISEASEDepartment of Health and Human Services$3.1M obligationsEnds Sep 29, 2027
PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIESDepartment of Health and Human Services$11.3M obligationsEnds Dec 31, 2026
BIOLOGICS IDIQ TASK ORDER- NON-GLP TOXICITY AND TOXICOKINETIC STUDIES IN RODENTS AND NON-RODENTS FOR A NOVEL, SUBCUTANEOUSLY-DOSED MODIFIED-HEPARIN DRUGDepartment of Health and Human Services$348.2K obligationsEnds Sep 28, 2026
TASK ORDER 1 BASE AWARD; BIOD CAN 8470038 $132,813Department of Health and Human Services$870.1K obligationsEnds Apr 17, 2025
DEEP ANTIBODY PROFILING FOR RSV INFECTION AND VACCINATIONDepartment of Health and Human Services$843.9K obligationsEnds Nov 30, 2025
CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATESDepartment of Health and Human Services$6.4M obligationsEnds Apr 17, 2025
EVALUATION OF CLINICAL SAMPLES FROM INFLUENZA CLINICAL TRIALSDepartment of Health and Human Services$2.9M obligationsEnds Apr 17, 2025
PIVOTAL STUDY TO EVALUATE THE EFFICACY OF S315 MAB AFTER PARENTERAL CHALLENGE OF DIPHTHERIA TOXIN IN A GUINEA PIG MODELDepartment of Health and Human Services$1.1M obligationsEnds Apr 17, 2025
NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES IN MINIPIGS AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDEDepartment of Health and Human Services$2.5M obligationsEnds Mar 25, 2027
CREATION OF A SUDAN EBOLAVIRUS INTERNATIONAL STANDARDDepartment of Health and Human Services$657.9K obligationsEnds Oct 31, 2025
DEVELOPMENT OF ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS) FOR NINDS NIH BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROJECTDepartment of Health and Human Services$531.2K obligationsEnds Feb 6, 2028
HAMSTER SARBECOVIRUS CHALLENGE MODEL FOR VACCINE TESTINGDepartment of Health and Human Services$2.4M obligationsEnds Sep 5, 2026
VALIDATION OF BIOANALYTICAL ASSAYS AND IND- ENABLING GLP PD/PK TOXICOLOGY STUDIES IN RATS AND DOGSDepartment of Health and Human Services$1.6M obligationsEnds Mar 10, 2027
LIQUID CHROMATOGRAPHY WITH TANDEM MASS SPECTROMETRY (HPLC-MS-MS) ASSAY VALIDATION AND SAMPLE TESTINGDepartment of Health and Human Services$494.7K obligationsEnds Jun 15, 2028
CLINICAL SAMPLE TESTING USING INTRACELLULAR FLOW CYTOMETRY USING SAMPLES FROM A PHASE 1 CLINICAL, OVX836; BIOD CAN 8040917; $838,705Department of Health and Human Services$612.8K obligationsEnds Sep 30, 2021